You are here

Our new paper in Gastroenterology is out!

March 2019

Despite effective antiviral therapies, the risk for hepatocellular carcinoma is not eliminated following viral cure of an HCV infection. This new publication sheds light on the role of HCV-induced persistent epigenetic changes in liver cancer risk. This research highlights the value of epigenomic analysis for earlier detection and improved management of hepatocellular carcinoma.


HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response. Hamdane N. et al. Gastroenterology. 2019 Jun;156(8):2313-2329.e7.

The paper can be accessed freely here.

Find the press release here.